Hubei Biocause Heilen Pharmaceutical: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders of Hubei Hengdi Pharmaceutical Co., Ltd.

SZSI · May 31

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.